|
1. Smith AD, Cowan JO, Filsell S, McLachlan C,
Monti-Sheehan G, Jackson P, Taylor DR.
Diagnosing asthma - Comparisons between exhaled
nitric oxide measurements and conventional
tests. Am J Respir Crit Care Med 2004;169:473-8.
2. Malmberg LP, Pelkonen AS, Haahtela T,
Turpeinen M. Exhaled nitric oxide rather than
lung function distinguishes preschool children
with probable asthma. Thorax 2003;58:494-9.
3. Massaro AF, Gaston B, Kita D, Fanta C,
Stamler JS, Drazen JM. Expired nitric oxide
levels during treatment of
acute asthma. Am J Respir Crit Care Med
1995;152:800-3.
4. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS,
Hung CH. A single dose of nebulized budesonide
decreases exhaled nitric oxide in children with
acute asthma. J Pediatr 2001;139:433-7.
5. Kharitonov SA. Exhaled markers of
inflammatory lung diseases: ready for routine
monitoring? Swiss Med Wkly 2004;134:175-92.
6. Smith AD, Cowan JO, Brassett KP, Filsell S,
McLachlan C, Monti-Sheehan G, Herbison GP,
Taylor DR. Exhaled Nitric Oxide A Predictor of
Steroid Response. Am J Respir Crit Care 2005;
172:453-459.
7. Silkoff PE, Carlson M, Bourke T, Katial R,
Ogren E, Szefler SJ. The Aerocrine exhaled
nitric oxide monitoring system NIOX is cleared
by the US Food and Drug Administration for
monitoring therapy in asthma. J Allergy Clin
Immunol
2004;114:1241-56.
8. Silkoff PE, McClean PA, Spino M, Erlich L,
Slutsky AS, Zamel N. Dose response relationship
and reproducibility
of the fall in exhaled nitric oxide after
inhaled beclomethasone dipropionate therapy in
asthma patients. Chest 2001;119:1322-8.
9.Nordvall SL, Janson C, Alving K. Agreement
between a stationary FENO system and the new
hand-held FENO analyzer for FENO measurements in
adults and children. World Allergy Congress.
Munich 2005. Poster session 1, Poster No. 164.
10. Alving K, Jansson C, Nordvall L. Performance
of a new hand-held device for exhaled nitric
oxide measurement in adults and children. Respir
Res 2006;7:67.
11. Hemmingsson T, Linnarsson D, Gambert R.
Novel Hand-held device for exhaled nitric oxide
analysis in research and clinical applications.
J Clin Moni Comput 2004;18:379-87.
12. Sovijärvi A, Järvinen H, Uusi-Simola J,
Nikkinen P, Piirilä P. Accuracy and
repeatability of a hand-held nitric oxide
analyzer in adults with respiratory symptoms.
ERS Annual Congress, Copenhagen 2005, Poster
3670.
13. Vahlkvist S, Sinding M, Skamstrup K,
Bisgaard H. Daily home measurements of exhaled
nitric oxide an asthmatic children during
natural birch pollen exposure. J. Allergy Clin
Immunol 2006;117:1272-1276.
14. Pijnenburg MW, Floor SI, Hop WC, De Jongste
JC. Daily
ambulatory exhaled nitric oxide measurements in
asthma. Pediatr Allergy Immunol 2006;17:189-193.
15. ATS/ERS Recommendations for Standardized
Procedures for the Online and Offline
Measurement of Exhaled Lower Respiratory Nitric
Oxide and Nasal Nitric Oxide, 2005. Am J Respir
Crit Care 2005;171:912-30.
NIOX MINO® is CE-marked according to Medical
Device Directive MDD 93/42/EEC and approved for
clinical use in EEC countries. US Patent
5,447,165, US Patent 5,922,610, US Patent
6,038,913, US Patent 6,063,027, US Patent
6,099,480, US Patent 6,149,606, US Patent
6,183,416, US Patent 6,511,425, US Patent
6,626,844, US Patent 6,723,056, US Patent
6,761,185 and patents pending. NIOX MINO and
NIOX are registered trademarks of Aerocrine AB.
- Improving management and care of
patients with inflammatory disorders
Aerocrine AB, P.O. Box 1024,
SE-171 21 Solna, Sweden.
Phone +46 8 629 07 80. Fax +46 8 629 07 81.
E-mail info@aerocrine.com
www.aerocrine.com
|
